Condition
Overweight
Obesity
Locations
United States
Start date
24/02/2026
Identifiers
Trial ID NN6989-8611,
NCT number NCT07437079,
Eudract number Not Available
NCT number NCT07437079,
Eudract number Not Available
Summary
This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is still being tested in studies and is not yet available for prescription by doctors. In this study, participants will receive either NNC6989-0001 or a placebo; which treatment each participant receives will be decided by chance.
Trial Overview:
Treatment
DRUG: NNC6989-0001
DRUG: Placebo (NNC6989-0001)
Study type
INTERVENTIONAL
Trial duration
Feb 24 2026 - Jan 21 2027
Participants
132
Phase
I
Are you eligible?
Gender
Male and female
Age
18 to 55 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.